-
艾媒报告|2020中国独角兽TOP100榜单及标杆企业研究报告
本报告研究涉及企业/品牌/案例:乂学教育-松鼠Ai 1对1,每日优鲜,美菜网,微医,联影医疗,快手,云从科技,滴滴出行,小鹏汽车,菜鸟网络,苏宁金融,柔宇科技,奇安信;其他提及企业/品牌:阿里巴巴,腾讯,京东,蚂蚁金服,京东数科,橙行智动,字节跳动 ,智者天下,度小满,小桔科技,商汤科技,喜马拉雅,地平线,陆金所,云杉世界,搜车网 ,满帮集团,云从科技,深兰科技 ,威马汽车,银联商务,车和家,大疆创新,微医云,小船出海,悦易网络,微众银行,优必选,猿力教育,寒武纪元,比特大陆,柔宇科技,行吟信息,拜腾汽车,小屋信息 ,优客工场,准时达,车好多,自如,智车优行,依图科技,葆扬投资,彬讯科技,钱大妈,一起作业,呯嘭智能,涂鸦科技,奥比中光,洋码头,麒麟合盛,途家在线,密境和风,图森未来,蚂蜂窝,纳恩博,悦畅科技,特斯联,新潮传媒,优行科技,第四范式,碳云智能,同盾科技,一点网聚,云知声,随手科技,八戒网络,数梦工场,首约科技,小马智行,虫极科技,联易融,诺禾致源,魅族,博鳌纵横,找钢网,圆心科技,影谱科技,氪空间,越海全球,花旺在线,快跑信息,丰巢科技,医云科技,淘友天下,华云数据,沪江教育,酒仙网,易动纷享,羽扇智,适赫物流,辣妈帮,贝贝集团,斑马网络,初速度,汇通天下,连尚网络
iiMedia Research(艾媒咨询)数据显示,2020年中国独角兽TOP100企业中,地域方面,北京、上海和深圳分别出现39、20和15家独角兽企业,总占比达74%;行业领域方面,人工智能与电商零售领域的独角兽企业发展较为迅速,上榜企业达33家。受益于新兴技术以及庞大的消费人群,与大众消费相关的独角兽企业发展较快,数量占到46%。艾媒咨询分析师认为,在2020年新冠疫情的影响下,中国宏观经济下行压力加剧,独角兽企业也将面临全新的机遇和挑战,一方面不少独角兽企业将受益于国家新老基建投资以及内需扩容提质等政策刺激快速发展,另一方面在全球经济增速放缓的情况下独角兽企业也将面临更激烈的竞争,生存发展压力加剧。
Among the unicorn TOP100 companies in China in 2020, Beijing, Shanghai and Shenzhen have 39, 20, and 15 unicorn companies accounted for 74% of the total; in the field of industry, unicorn companies in the field of artificial intelligence and e-commerce retail developed rapidly, with 33 companies on the list. Benefiting from emerging technologies and a large consumer population, unicorn companies related to mass consumption have developed rapidly, accounting for 46% of the total. iiMedia Consulting analysts believe that under the influence of the new crown epidemic in 2020, China's macroeconomic downward pressure will increase, and unicorn companies will also face new opportunities and challenges. On the one hand, many unicorn companies will benefit from national infrastructure Policies such as investment and domestic demand expansion and quality spur rapid development. On the other hand, with the global economic growth slowing down, unicorn companies will also face more intense competition and intensify the pressure on survival and development. -
艾媒报告 |2019全球及中国大健康产业运行大数据及决策分析报告
本报告研究涉及企业/品牌/案例:恒瑞医药,白云山,111集团,平安好医生,好大夫在线,优健康,春雨医生,微医,丁香医生,和美医疗,北大医疗,PHG,新氧,联合丽格,正广兴家庭医生,强森医疗,微脉,美中嘉和,零氪科技,中有精准医疗,思派网络,普瑞眼科,臻和科技,移宇科技,小鹿医馆,妈咪知道,八百方,京东医药,阿里健康大药房,1药网,一心堂,健一网,好药师,健客网,美丽神器,更美,悦美,美莱整形,伊美尔,丽都整形,芝星整形,欧华美科
大健康产业细分领域的垂直深化,推动了大健康产业格局的不断完善。受政策鼓励和资本推动的影响,2019年,大健康产业在患者服务类领域、医疗服务类领域、医药服务类领域、医疗美容类领域和医疗保健类领域等细分场景快速发展。以恒瑞医药、白云山为代表的传统医药上市公司和以平安好医生、111集团和新氧科技为代表的互联网医疗上市企业各自占据大健康产业领域的一席之地。艾媒商情舆情监测系统数据显示,受2018年和2019年上半年医疗领域负面舆情的影响,大健康产业各上市企业正从低谷平稳回升。艾媒咨询分析师认为,受社会医疗需求和国家政策的推动,大健康产业仍是未来投资的亮点。
The vertical deepening of the large health industry segment has promoted the continuous improvement of the pattern of the big health industry. Influenced by policy encouragement and capital promotion, in 2019, the big health industry developed rapidly in the sub-sectors such as patient service, medical services, medical services, medical and beauty, and health care. The traditional pharmaceutical listed companies represented by Hengrui Medicine and Baiyun Mountain and the Internet medical listed companies represented by Ping An Doctor, 111 Group and New Oxygen Technology each occupy a place in the field of large health industry. According to data from the Aibu Business Intelligence Monitoring System, the listed companies in the big health industry are recovering steadily from the bottom of the market due to the negative public sentiment in the medical field in the first half of 2018 and 2019. Ai Media Consulting analysts believe that the health industry is still the highlight of future investment, driven by social medical needs and national policies. -
艾媒报告 |2019年中国柔性显示产业研究与商业投资决策分析报告
本报告研究涉及企业/品牌包括:三星、iPhone、华为、小米、OPPO、京东方、深天马A、TCL集团、微信诺、华星光电、信利国际、和辉光电、柔宇科技、中能源、湖南群显、联得装备、同兴达、志云股份、国风塑业、新纶科技、时代新材、鼎龙股份、激智科技、晶华新材、万润股份、强力新材、东旭光电、莱宝高科、长信科技、ST康得新、中颖电子、士兰微、凯盛科技、康达新材、西部材料、传艺科技、金明精机、光莆股份、样子想你才、神宇股份、海顺新材、茂硕电源
政策支持和技术进步共同推动中国柔性显示产业快速发展。iiMedia Research(艾媒咨询)监测发现,2018年中国柔性显示游产业链各个环节相关企业营收均超亿元,相关上市公司中京东方A(000725.SZ)的网络关注度最高,隆华科技(300263.SZ)的网络口碑最好。但由于技术门槛高等相关因素影响,中国柔性显示产业上游发展基础薄弱,产业存在发展不成熟、技术欠缺和市场份额不足等问题。
The scale of China's bio-pharmaceutical industry continues to grow, and the proportion of bio-pharmaceutical output in the pharmaceutical industry continues to rise. In 2017, the total output value of the bio-pharmaceutical industry in China's park was about 1.5 trillion yuan. At present, China's biomedical industry has formed three major clusters, including the Bohai Rim region, the Yangtze River Delta region and the Pearl River Delta region, and the industrial agglomeration effect is outstanding. China's bio-pharmaceutical industry is in a stage of rapid development. In 2018, many head-to-head listed companies in biomedical related fields such as monoclonal antibodies, blood products and vaccines all exceeded 100 million yuan, achieving year-on-year growth. According to iiMedia Research, netizens in Shanghai are most concerned about the biomedical industry, and 40.9% of netizens surveyed support the application of transgenic technology in the pharmaceutical field. Among the heads of monoclonal antibodies, blood products and vaccines, Fuhong Hanlin as well as Weiguang Bio and Lidmanthe has the best online reputation,iiMedia Consulting analysts believe that in the future, the combination of artificial intelligence with new drug research and the fierce competition among head enterprises is an important trend in the development of China's biomedical industry. -
艾媒报告 |2018-2019中国宠物食品产业研究与商业投资决策分析报告
本报告研究涉及企业/品牌包括:Thompson Street Capital Partner、Tropichem实验室、TetraGenx、Genoscoper、全球宠物用品控股公司GPP、荷兰国际投资公司ING、Schlotus、General Mills、Blue Buffalo、J.M.Smucker、Ainsworth Pet Nutrition、LLC(安斯沃思宠物营养品)公司、United Petfood、Animal Lovers、Nestle、Wamiz、Purina、荷兰IMCD、宠幸宠物、魔力猫盒、宠爱国际、疯狂的小狗、猫殿下、味及、宠安安、宠物之城、瑞派宠物、兴牧生物、宠爱堡、派迪畅科技、宇钛科技、云宠智能、爱宠医生、双安科技、皇家、比瑞吉、渴望、麦富迪、亚禾、顽皮、伊纳宝、伟嘉、喵趣、希宝、宝路、优卡、西莎、佳贝、冠能、康多乐、普瑞纳、妙多乐、喜跃、Wanpy、中宠、Kingdom PetS、Live、纯真肉本色、Dr Hao、脆脆香、Sea、Kingdom、KingKitty、Frisian、Mio9、佩蒂股份
iiMedia Research(艾媒咨询)数据显示,2018年中国养宠家庭超6000万,宠物饲养和饲养宠物家庭数量有明显增多。然而,在国外品牌具有明显优势的挑战下,中国宠物食品行业正面临跨越性发展以及生存双重压力,宠物食品企业还需在渠道、品质和品牌建设等方面投入发展。
As the data of iiMedia Research showed, the pet food industry reached 93.4 billion yuan in the market in 2018, with a growth rate of 86.8%. The growth rate is much higher than that of previous years. With the change of people's pet concept and the promotion of pet status, users are willing to spend more on pet food to protect the health and growth of pets. The overall situation of pet food industry is better.
没找到想要的报告?
扫码添加客服参与预约/定制,第一时间获取行业推荐报告!
智库热榜
艾媒咨询|2024-2025年中国银发经济投资前景分析报告
艾媒咨询|2024-2025年中国烘焙食品行业现状及趋势研究报告
艾媒咨询 | 2023-2024年中国休闲食品产业现状及消费行为数据研究报告
艾媒咨询|2024-2025年全球及中国新能源汽车行业消费趋势监测与案例研究报告
艾媒咨询 | 2023-2024年中国全域旅游产业运行数据及发展趋势研究报告
艾媒咨询 | 2024年中国家用美容仪行业消费者洞察研究报告
艾媒咨询|赵一鸣零食店消费行为洞察及行业趋势报告(2024)
艾媒咨询|2024年中国月饼行业创新发展研究报告
艾媒咨询 | 2024年中国数字中台市场研究报告
艾媒咨询|2023-2024年全球及中国跨境电商运营数据及典型企业分析研究报告
艾媒咨询|2024年中国家清产品消费趋势洞察报告